Literature DB >> 15894502

[Indications for use of labile blood products and the physiology of blood transfusion in medicine. The French Agency for the Health Safety of Health Products].

H Gouëzec1, P Jego, Pierre Bétrémieux, Stanislas Nimubona, Isabelle Grulois.   

Abstract

This article presents the French national recommendations for the use of blood products in medicine.

Mesh：

Substances：

Year:  2005        PMID： 15894502     DOI： 10.1016/j.tracli.2005.04.011

Source DB:  PubMed          Journal:  Transfus Clin Biol        ISSN： 1246-7820            Impact factor:   1.406


  5 in total

Review 1.  Recommendations for the transfusion of plasma and platelets.

Authors:  Giancarlo Liumbruno; Francesco Bennardello; Angela Lattanzio; Pierluigi Piccoli; Gina Rossetti
Journal:  Blood Transfus       Date:  2009-04       Impact factor: 3.443

2.  Recommendations for the transfusion management of patients in the peri-operative period. III. The post-operative period.

Authors:  Giancarlo Maria Liumbruno; Francesco Bennardello; Angela Lattanzio; Pierluigi Piccoli; Gina Rossetti
Journal:  Blood Transfus       Date:  2011-04-20       Impact factor: 3.443

3.  Recommendations for the transfusion management of patients in the peri-operative period. II. The intra-operative period.

Authors:  Giancarlo Maria Liumbruno; Francesco Bennardello; Angela Lattanzio; Pierluigi Piccoli; Gina Rossetti
Journal:  Blood Transfus       Date:  2011-04       Impact factor: 3.443

4.  Patient blood management in Europe.

Authors:  A Shander; H Van Aken; M J Colomina; H Gombotz; A Hofmann; R Krauspe; S Lasocki; T Richards; R Slappendel; D R Spahn
Journal:  Br J Anaesth       Date:  2012-05-24       Impact factor: 9.166

5.  [Spontaneous hematoma of right angle of the transverse mesocolon: exceptional complication of anticoagulant therapy with vitamin K].

Authors:  Ibrahim Alain Traoré; Cyprien Zaré; Sié Drissa Barro; Ismaël Guibla
Journal:  Pan Afr Med J       Date:  2016-02-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.